68.54 
0.21(0.31%) May 21, 4:02PM EDT
| Prev Close: | 68.33 |
|---|
| Open: | 68.78 |
|---|
| Bid: | 55.00 x 200 |
|---|
| Ask: | 79.08 x 100 |
|---|
| 1y Target Est: | 79.00 |
|---|
| Beta: | 0.91 |
|---|
| Next Earnings Date: | 22-Jul-13 |
|---|
| Day's Range: | 68.12 - 68.78 |
|---|
| 52wk Range: | 54.06 - 82.00 |
|---|
| Volume: | 237,604 |
|---|
| Avg Vol (3m): | 267,173 |
|---|
| Market Cap: | 1.29B |
|---|
| P/E (ttm): | 14.49 |
|---|
| EPS (ttm): | 4.73 |
|---|
| Div & Yield: | 0.72 (1.10%) |
|---|
The broker you select will become the default broker for Trade Now
Quotes delayed, except where indicated otherwise. Currency in USD.
Headlines
- CHEMED CORP Files SEC form 8-K, Submission of Matters to a Vote of Security HoldersEDGAR Online(Tue, May 21)
- 3 Health Care Stocks Spiking on Big Volumeat TheStreet(Tue, May 21)
- Chemed Keeps Dividend Steadyat Motley Fool(Mon, May 20)
- Chemed Corporation Holds Annual Meeting of Shareholders; Board Declares Quarterly DividendBusiness Wire(Mon, May 20)
- Law Offices of Todd M. Garber Announces Investigation of Chemed CorporationBusiness Wire(Mon, May 20)
- CHEMED CORP Files SEC form 8-K, Other EventsEDGAR Online(Thu, May 16)
- Chemed Corporation to Present at the UBS Global Healthcare ConferenceBusiness Wire(Tue, May 14)
- Abraham, Fruchter & Twersky, LLP Announces Investigation of Chemed Corp.Business Wire(Tue, May 14)
- Ryan & Maniskas, LLP Announces Investigation of Chemed Corp.PR Newswire(Mon, May 13)
- Glancy Binkow & Goldberg LLP Announces Investigation of Chemed CorporationBusiness Wire(Mon, May 13)
- U.S. to Join Chemed Whistle-Blower Suit on Medicare Claimat Bloomberg(Fri, May 10)
- Chemed Corporation Is Being Investigated on Behalf of ShareholdersPR Newswire(Fri, May 10)
- Largest US hospice company sued for Medicare fraudAP(Thu, May 9)
- Morgan & Morgan Announces the Investigation of Chemed Corporation (NYSE: CHE)PR Newswire(Wed, May 8)
- Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses In Excess Of $100,000 Investing In Chemed Corporation To Contact The FirmPR Newswire(Tue, May 7)
Key Statistics
| Forward P/E (1 yr): | 11.40 |
|---|
| P/S (ttm): | 0.89 |
|---|
| Ex-Dividend Date: | 28-Feb-13 |
|---|
Analysts
| Annual EPS Est
(Dec-13)
: | 5.66 |
|---|
| Quarterly EPS Est
(Jun-13)
: | 1.33 |
|---|
| Mean Recommendation*: | 2.4 |
|---|
| PEG Ratio (5 yr expected): | 0.93 |
|---|
Business Summary
Chemed Corporation, through its subsidiaries, operates in the healthcare, and repair and maintenance fields in the United States. The company operates in two segments, Vitas and Roto-Rooter.
View More